Incannex Healthcare Inc. 8-K

What Happened Incannex Healthcare Inc. announced it has mutually terminated its Amended and Restated Sales Agreement with Curvature Securities, LLC and A.G.P./Alliance Global Partners, effective March 11, 2026. The original Sales Agreement (amended from an April 7, 2025 agreement) allowed the company to sell shares of common stock through the sales agents. During the agreement’s term, Incannex sold shares for aggregate gross proceeds of approximately $108.4 million. The company also updated its corporate presentation on March 12, 2026 and issued a press release describing these developments.

Key Details

• Termination date: March 11, 2026; agreement was mutual and effective immediately.
• Parties: Incannex Healthcare, Curvature Securities, LLC, and A.G.P./Alliance Global Partners.
• Proceeds raised under the Sales Agreement: approx. $108.4 million (aggregate gross).
• Corporate presentation updated March 12, 2026; presentation and press release furnished as exhibits to the 8-K.

Why It Matters The terminated sales agreement was the mechanism Incannex used to sell shares to the market and raised roughly $108.4M in gross proceeds while it was in effect. Its termination means the company no longer has that specific at-the-market (ATM) sales arrangement in place with those sales agents; investors should note this change in the company’s capital-raising tools and check the updated investor presentation and press release for any discussion of future financing plans or strategy.